Humoral factors in ALS patients during disease progression. - Wikidata - awgldk - TriplyDB

Humoral factors in ALS patients during disease progression.

Humoral factors in ALS patients during disease progression.

http://www.wikidata.org/entity/Q35806256

about

Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis.Evaluating the levels of CSF and serum factors in ALS Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study.Cord blood as a potential therapeutic for amyotrophic lateral sclerosis.Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.Further development of biomarkers in amyotrophic lateral sclerosis.Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism.Contrasting effect of the latency-reversing agents bryostatin-1 and JQ1 on astrocyte-mediated neuroinflammation and brain neutrophil invasion.Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis.Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients.Adipsin, MIP-1b, and IL-8 as CSF Biomarker Panels for ALS Diagnosis

P2860

Q37487611-1BAC0268-9380-4FC1-81F3-8134E6D7B573 Q37694392-05CC7A61-19F3-4492-BB8A-D7843A804338 Q38613326-F6D0156D-6827-40C4-942E-680A1DA88B47 Q38690849-2E8F0E48-E17A-4A1B-92F3-05013D6EC45F Q38822774-A92AE852-18E8-4E18-B176-FE1FA85357CB Q38856405-241A5BAC-4A85-45EF-A6C0-FFE6D4F52E4B Q39033841-8A31E392-BA9B-4939-83BB-A0F953997640 Q41585035-F3E26156-F588-4C8B-88F7-0DCD4ECE79C9 Q47147442-0C62CE63-987F-46A2-BF23-C50B48A01988 Q47829271-EC62CEE4-D21C-477C-A851-BEBE2A53F59D Q51758743-27664D65-41FC-4C66-8750-E42FECD975B8 Q58575478-23F2C08B-7583-40B6-B526-DBC931CD0245

P2860

Humoral factors in ALS patients during disease progression.

http://www.wikidata.org/entity/Q35806256

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Humoral factors in ALS patients during disease progression.

@ast

Humoral factors in ALS patients during disease progression.

@en

type

label

Humoral factors in ALS patients during disease progression.

@ast

Humoral factors in ALS patients during disease progression.

@en

prefLabel

Humoral factors in ALS patients during disease progression.

@ast

Humoral factors in ALS patients during disease progression.

@en

P1433

Q35806256-15BB7C73-F49B-4E54-8E20-D74EF8E2E831

P1476

Q35806256-A06A8F4E-6A70-4330-A13E-4B03F5FA3D16

P2093

Q35806256-110A79A5-977D-47D5-A00E-ECBB54D0025D

Q35806256-1A6B63A8-A13A-41B9-AEF3-D823EBDDE2D8

Q35806256-1B267EEC-0F4A-45A9-B413-DDDA9892B0E1

Q35806256-37616AB5-74FD-4FEC-A7A8-81A408D755A2

Q35806256-3AF81F64-4FC1-4846-BEF8-9F97AB84BB02

Q35806256-48FF9B73-9FCC-4405-A229-93852A359C32

Q35806256-5D3B9A80-EF65-448D-8C2E-A3FBCEC43CF2

Q35806256-6CB00CCB-4B3A-4A00-B031-8F315378A28D

Q35806256-A5B7AF7F-17AF-478B-A60C-8B509210CE64

Q35806256-A8F8C69A-A13A-4575-B2AA-819A068065F0

P2860

Q35806256-014060A0-42DC-47C0-B79E-CECCD2A028C1

Q35806256-028E1899-279B-4241-BC1F-5E7576E721D1

Q35806256-05130C3B-783B-45AF-AFBC-1F409814ABFE

Q35806256-060573BE-63B7-46E3-80F6-85E1CC6287D5

Q35806256-0898BCE7-A713-4328-8312-A499A5F6D13D

Q35806256-08A74DEF-7CFB-41D5-98BA-F17F7A03F539

Q35806256-0927C994-FDE7-48DB-91B3-3A7C547C1EF5

Q35806256-0F712E4E-73B4-4B79-9DC0-3B565EAD760D

Q35806256-133102A9-28AC-40AB-9787-D0421077A107

Q35806256-1438D5AC-A326-4EC9-B55E-FD28A520DBEA

P2888

Q35806256-A7D0C9ED-2EA5-4B3D-9304-B33AED605E33

P304

Q35806256-F84238D6-0F69-4656-9D2F-0A6AC7F8384A

P31

Q35806256-4D46E8E3-BAB8-4393-AF5F-0FA2FDB68FA3

P356

Q35806256-FFBDCF0D-4E20-424C-B4D4-1BE2F744919E

P478

Q35806256-E196C357-0EEA-42B7-B1A2-EC21FB0D1F39

P50

Q35806256-09FE1258-2AD0-4AFC-8E49-5209EFD3EA38

P577

Q35806256-9C3991DB-01F6-4D07-B305-5C9431AA54B4

P5875

Q35806256-F2EF1632-12E9-48B7-A793-40CFDCDB9847

P6179

Q35806256-A70D8426-6ABC-4678-B69D-D401DEB90BD4

P698

Q35806256-EBC0FBD1-C527-4EEF-B31F-7FCE6A309DAC

P921

Q35806256-A3411DB9-AAAE-4188-BBE5-119F59965C17

P932

Q35806256-A6181152-11F8-4E51-BA73-89D463CCB271

P356

S12974-015-0350-4

P1433

Journal of Neuroinflammation

P1476

Humoral factors in ALS patients during disease progression

@en

P2093

Adam J Smith

http://www.w3.org/2001/XMLSchema#string

Cyndy D Sanberg

http://www.w3.org/2001/XMLSchema#string

Israt Jahan

http://www.w3.org/2001/XMLSchema#string

Jared Ehrhart

http://www.w3.org/2001/XMLSchema#string

Nicole Kuzmin-Nichols

http://www.w3.org/2001/XMLSchema#string

Paul R Sanberg

http://www.w3.org/2001/XMLSchema#string

R Douglas Shytle

http://www.w3.org/2001/XMLSchema#string

Seol-Hee Kim

http://www.w3.org/2001/XMLSchema#string

Svitlana Garbuzova-Davis

http://www.w3.org/2001/XMLSchema#string

Theresa A Zesiewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation

Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells

Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion

Dysregulation of glutathione homeostasis in neurodegenerative diseases

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Regulation of the immune response by the interaction of chemokines and proteases

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines

Interleukin-5, eosinophils, and disease

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

P2888

s12974-015-0350-4

P304

127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12974-015-0350-4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279530440

http://www.w3.org/2001/XMLSchema#string

P6179

1018760059

http://www.w3.org/2001/XMLSchema#string

P698

26126965

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4487852

http://www.w3.org/2001/XMLSchema#string